SIOX — Sio Gene Therapies Share News
0.000.00%
Last trade - 00:00Brief: Sio Gene Therapies Announces Fiscal Third Quarter 2022 Financial Results
Brief: Sio Gene Therapies Inc. Announces Board Approval Of Plan Of Complete Liquidation, Dissolution
Brief: Sio Gene Therapies Announces Second Quarter Financial Results
Brief: Sio Gene Therapies Announces Fiscal First Quarter 2022 Financial Results
Brief: Sio Gene Therapies Announces Fiscal Year 2021 Year-End Financial Results
U.S. STOCKS ON THE MOVE-Pinterest, Qualcomm, ServiceNow
Sio Gene Therapies slumps on plans to explore options including sale
Brief: Sio Gene Therapies Inc - Plans To Explore And Review A Range Of Strategic Alternatives
U.S. STOCKS ON THE MOVE-Cedar Fair, PG&E Corp, Chevron Corp
U.S. STOCKS ON THE MOVE-Exxon Mobil, Xometry, Gannett
Sio Gene Therapies hits record low as co scraps Parkinson's disease program
Sio Gene Therapies down on scrapping Parkinson's drug development, CEO exit
Sio Gene Therapies down on scrapping Parkinson's disease drug development
Brief: Sio Gene Therapies Appoints David Nassif Interim CEO
Sio Gene Therapies falls as Q2 loss widens
Brief: Sio Gene Therapies Reports Q2 Loss Per Share Of $0.29
U.S. STOCKS ON THE MOVE-Oscar Health, Paysafe, Bumble
U.S. STOCKS ON THE MOVE-Affirm, Rivian, Bright Health
Sio Gene up on successful manufacturing of Parkinson's disease therapy